Collectively, these results indicate that CPPtat-V1 inhibits O-GlcNAc modification of VEZF1 and induces its proteasomal dependent degradation, thereby reducing TNS1 expression in HCC cells. The gene discussed is VEZF1; the disease is hepatocellular carcinoma.